COVID-19: What You Should Know

It’s hard to stay calm when the world is upside down. This is particularly true for people going through cancer, who are especially vulnerable to infection. Fortunately, there are tips and tools for how to cope from our partners at Memorial Sloan Kettering. #StaySafeStayHome How can I protect myself from getting COVID-19? You can protect…

Read More

2019 Kristen Ann Carr Fund Holiday Letter

Dear Family, Friends, Colleagues and Supporters, Happy Holidays to all! We are heading into our 27th year in our fight against sarcoma. All those years ago Kristen asked Dr. Murray Brennan, her physician and then chief of surgery at MSKCC and a sarcoma expert, “what do you need”? Murray responded that we need surgeons and…

Read More

FROM THE KACF SARCOMA LAB AT MEMORIAL SLOAN KETTERING

Support from the Kristen Ann Carr Fund (KACF) will fully fund Memorial Sloan Kettering Cancer Center (MSK) senior research technician Lei Zhang, PhD, as she works to uncover the genes that drive the development of rare sarcomas in children and young adults. Using state-of-the-art genetic sequencing and the genome-editing tool CRISPR-Cas9, Dr. Zhang and her…

Read More

Team KACF Rides Again: 6th Year Participating in Cycle for Survival

Cycle for Survival, which ranks as the fastest growing athletic fundraiser in the country, attracted 31,000 participants in 16 cities across the United States and internationally.  Equinox Clubs, which hosts the rides propelled Cycle for Survival to reach an incredible $200 million! It takes a movement powered by a fierce and dedicated community to reach…

Read More

2018 A Record-Breaking Year!

Our 25th Anniversary Gala last April 21st was another amazing A Night to Remember. Hosted by Barbara Carr, Dave Marsh and Sasha Carr, Kristen’s legacy was front and center as the evening was shared with many longtime supporters and new friends. Over 400 guests dined on the always exceptional cuisines from Tribeca Grill, NOBU, Batard,…

Read More

2018 Kristen Ann Carr Fund Holiday Letter

  Dear Friends, This letter is our annual message to those who have, for the past 25 years, been our collaborators in creating The Kristen Ann Carr Fund. The letter serves as a report on what we’re planning, a compilation of memories of what’s already been done in Kristen’s name, and a description and assessment…

Read More

Sarcoma Research Led by Aimee Crago, MD, PhD

Ongoing support from the Kristen Ann Carr Fund (KACF) to Memorial Sloan Kettering Cancer Center (MSK) is funding critical research in the laboratory of Aimee Crago, MD, PhD, a surgeon specializing in soft tissue sarcomas. Surgical removal of well- and de-differentiated liposarcomas is almost universally followed by an aggressive recurrence of these cancers. Systemic treatments,…

Read More

2017 Kristen Ann Carr Fund Holiday Letter

December 2017 Dear friends, The 1992 holiday season found us at our lowest point . Kristen’s illness had grown much worse. We had yet to understand that we were trying to stop a locomotive with our bare hands. By the first week of January 1993, about all we knew was an urgent need to keep…

Read More

The Kristen Ann Carr Fund welcomes the 2017/2018 Surgical Fellow, Edmund (Ned) King Bartlett, MD

Dr. Bartlett will gain extensive clinical experience at MSK, where he’ll study recurrence patterns in patients with liposarcomas in their arms or legs. Liposarcomas are the most common type of sarcoma (approximately 20% of all such tumors). There are also several sub-types: well difrerentiated, dediferentiated, pleomorphc, myxoid, round cell. The clinical significance of these subtypes…

Read More

Funding from The Kristen Ann Carr Fund Propels the Work of World-Renowned Pathologist and Director of Bone and Soft Tissue Pathology at Memorial Sloan Kettering Cancer Center, Cristina Antonescu, MD

Dr. Antonescu’s research centers on the deep molecular characterization of rare sarcomas that strike children and young adults. The essence of precision medicine, these critical data point to the inner workings of a tumor, and are used to guide treatment decisions. The Fund is supporting Dr. Antonescu’s study of tumors that contain “simple” genetic abnormalities,…

Read More